China Pharmaceuticals and Healthcare Report

Marketreportsonchina.com presents a report on“China Pharmaceuticals and Healthcare Report”. The Chinese pharmaceutical and healthcare sector through our reviews of latest industry trends, regulatory changes and major deals, projects and investments in China.

Apr., 23nd, 2015, Mumbai, India: Market Reports on China presents the report, on “China Pharmaceuticals and Healthcare Report”.The latest financial and operating statistics and key company developments are also incorporated within the company profiles, enabling a full evaluation of recent company performance and future growth prospects

The China Pharmaceuticals and Healthcare Report features BMI Research's forecasts for drugs and healthcare expenditure and imports and exports, focusing on the growth outlook for the prescription, OTC, patented drugs and generics market segments.

BMI's China Pharmaceuticals and Healthcare Report provides industry professionals, strategists, company executives, investors, analysts and sales/marketing heads with independent forecasts and competitive intelligence on the China pharmaceutical and healthcare industry.

Key Benefits

Benchmark BMI's pharmaceutical and healthcare market forecasts for China, to test other views - a key input for successful budgeting and strategic business planning in the Chinese pharmaceutical and healthcare market.

Target business opportunities and risks in the Chinese pharmaceutical and healthcare sector through our reviews of latest industry trends, regulatory changes and major deals, projects and investments in China.

Assess the activities, strategy and market position of your competitors using our company profiles (including SWOTs, KPIs and latest activity) and competitive landscape tables.

Coverage

BMI Industry View

An at-a-glance perspective on the latest regulatory developments, key forecast indicators and major corporate developments, covering the prescription, OTC and generics markets. The pharmaceuticals and healthcare SWOT...